Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

GSK To Cut Prices To SE Asia’s Poorest, Seek Patent Changes

This article was originally published in PharmAsia News

Executive Summary

U.K.-based GlaxoSmithKline plans to reduce the price of its drugs in the world's 50 poorest countries, several of them in Southeast Asia. The company also plans to seek cooperation with other multinational drug makers to share patents for drugs that would be developed to treat 14 neglected tropical diseases that plague those countries. The price cut would set a cap of 25 percent of the cost in developed nations. GSK also said it would reinvest in those countries 20 percent of residual profits earned in them. Most of the 50 poorest nations are in Africa, but the United Nations also includes Afghanistan, Bangladesh, Cambodia, Laos, Myanmar and Nepal on the list. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC070791

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel